Brief: Oragenics Says Co Entered Into At-The-Market Sales Agreement With Dawson James Securities
Oct 15 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS INC SAYS ON OCTOBER 11, CO ENTERED INTO
AT-THE-MARKET
SALES AGREEMENT WITH DAWSON JAMES SECURITIES - SEC FILING
* ORAGENICS INC SAYS IT MAY OFFER COMMON SHARES OF UP TO $10
MILLION
Source text for Eikon: ID:n0001493152-24-040974
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing